TAMPA, Fla.--(BUSINESS WIRE)--Xcelience, a leader in early drug development services, recently expanded their GMP manufacturing capabilities with the purchase of three new pieces of equipment offering a solution to pharmaceutical companies facing the challenges of limited API.
